Finally, a high IL-6 serum level is often associated to worse progression-free survival and overall survival in Non Hodgkin Lymphoma [5], myeloma [6], renal carcinoma and breast adenocarcinoma [7], [8]. The gene discussed is IL6; the disease is non-Hodgkin lymphoma.